Integrative Multi-omic Profiling of Two Human Decedents Receiving Pig Heart Xenografts Reveals Strong Perturbations in Early Immune-Cell and Cellular Metabolism Responses

Eloi Schmauch, Brian Piening, Bo Xia, Chen Ouyang, Jeffrey Stern, Weimin Zhang, Alexa K. Dowdell, Bao‐Li Loza, Maedeh Mohebnasab, Loren Gragert, Karen Khalil, Brendan Camellato, Michelli F. Oliveira, Darragh P. O’Brien, Elaina Weldon, Xiangping Lin, Hui Gao, Larisa Kagermazova, Jacqueline Kim, Alexandre Loupy, Adriana Heguy, Sarah E. Taylor, Florrie Zhu, Sarah Gao, Divya Gandla, K Srinavas Reddy, Andrew C. Chang, Basil Michael, Lihua Jiang, Ruiqi Jian, Navneet Narula, Suvi Linna-Kuosmanen, Minna U. Kaikkonen, Marc I. Lorber, Manolis Kellis, Vasishta Tatapudi, David Ayares, Adam Griesemer, Massimo Mangiola, Harvey I. Pass, M Snyder, Robert A. Montgomery, Jef D. Boeke, Brendan J. KeatingbioRxiv 2023 · DOI

TL;DR

Researchers performed a massive "multi-omic" deep dive into the first two cases of pig-to-human heart xenotransplantation in brain-dead decedents. By tracking thousands of molecular signals every six hours, they identified early warning signs of rejection and metabolic failure that were completely invisible to standard hospital pathology, providing a high-resolution roadmap for future clinical trials.

What Problem Does This Paper Address?

The chronic shortage of human donor organs has made xenotransplantation—using genetically modified pig organs—a holy grail of modern medicine. However, the human immune system is incredibly aggressive toward foreign tissue. While recent "first-in-human" experiments in decedents (brain-dead patients kept on life support) have shown that pig hearts can function in a human body for a few days, we still lack a detailed understanding of the "molecular cross-talk" between the two species.

Standard clinical tools, like looking at tissue biopsies under a microscope (histology), often fail to detect the earliest stages of rejection. This paper addresses that "blind spot" by using advanced sequencing and mass spectrometry to see exactly how human immune cells and cellular metabolism react to a pig heart in real-time.

Methods

The authors employed Integrative Personal Omics Profiling (iPOP), a longitudinal approach that looks at biological systems holistically rather than one gene at a time. They collected blood and tissue samples every 6 hours over a 66-hour period.

Key techniques included:

  • Single-cell and Single-nuclei RNA-seq (sc/snRNA-seq): To identify exactly which types of human immune cells were activating and which pig heart cells were stressed.
  • Geospatial Transcriptomics (Visium): A cutting-edge technique that maps gene expression to specific physical locations in the heart tissue, allowing researchers to see where human immune cells were "infiltrating" the pig organ.
  • Mass Spectrometry: Used for high-throughput proteomics (proteins), metabolomics (small molecules), and lipidomics (fats) to track systemic physiological changes.
  • Fuzzy C-means Clustering: A machine learning approach used to integrate these disparate datasets and find synchronized patterns of change across different molecular layers.

Datasets

The study generated a massive, multi-modal dataset from two human decedents (referred to as D1 and D2):

  • Transcriptomic: 26 longitudinal scRNA-seq samples and bulk RNA-seq.
  • Proteomic: Over 1,000 protein groups identified via 16-Plex Tandem Mass Tag (TMT) MS.
  • Metabolomic/Lipidomic: 459 metabolites and 720 lipids tracked over time.
  • Reference Genomes: Data was aligned against both the human (GRCh38) and pig (Sscrofa11) genomes to distinguish between donor and recipient signals.

Key Insights and Ideas

  • The "Invisible" Rejection: In Decedent 1, standard histology showed no clear signs of rejection. However, the omics data revealed a "molecular storm" of T-cell activation and antibody-mediated rejection (AbMR) signals starting around 42 hours.
  • Immunosuppression Matters: Decedent 2 received a second dose of an immunosuppressant (rATG), which effectively "blunted" the T-cell response. In contrast, Decedent 1 (who only received one dose) saw a massive spike in CD4+ and CD8+ T-cells, likely contributing to the organ's decline.
  • Metabolic "Switch": The researchers observed a dramatic shift in Decedent 1’s metabolism toward glycolysis and pyruvate metabolism, alongside markers of liver damage. This suggests that as the heart struggled, the body entered a hypoxic (low oxygen) state, triggering systemic organ failure.
  • Spatial Hotspots: Geospatial mapping showed that human immune cells didn't just wander aimlessly; they clustered in specific "hotspots" within the pig heart, accompanied by inflammatory signals from the pig's own vascular cells.

Key Results

  • Divergent Trajectories: Decedent 1 showed profound physiological dysfunction starting at 30–36 hours, while Decedent 2 remained relatively stable throughout the 3-day study.
  • Molecular Signatures: In Decedent 1, researchers found a significant upregulation of pathways related to Antigen Presentation (q < 0.01) and Glycolysis (q < 5x10⁻¹³).
  • Cellular Infiltration: snRNA-seq confirmed that human macrophages and T-cells were actively infiltrating the pig heart tissue by day 3.
  • Clinical Correlation: The multi-omic clusters correlated perfectly with traditional clinical markers like ALT, AST (liver enzymes), and INR (clotting time), but provided the data much earlier and with more mechanistic detail.

Limitations and Future Work

The authors acknowledge several major hurdles:

  • Sample Size: With only two decedents, it is difficult to make broad generalizations.
  • Duration: The 3-day window is too short to observe long-term chronic rejection or the full effects of immunosuppression.
  • Suboptimal Regimen: The study did not use "costimulatory blockade" drugs, which are now considered essential for long-term xenograft survival.

Future Work: The authors suggest extending decedent studies to 30 days to better simulate clinical timelines and testing more robust immunosuppression protocols to see if the molecular "rejection signatures" identified here can be suppressed.

Summary updated

Abstract

ABSTRACT Background Recent advances in xenotransplantation in living and decedent humans using pig xenografts have laid promising groundwork towards future emergency use and first in human trials. Major obstacles remain though, including a lack of knowledge of the genetic incompatibilities between pig donors and human recipients which may led to harmful immune responses against the xenograft or dysregulation of normal physiology. In 2022 two pig heart xenografts were transplanted into two brain-dead human decedents with a minimized immunosuppression regime, primarily to evaluate onset of hyper-acute antibody mediated rejection and sustained xenograft function over 3 days. Methods We performed multi-omic profiling to assess the dynamic interactions between the pig and human genomes in the first two pig heart-xenografts transplants into human decedents. To assess global and specific biological changes that may correlate with immune-related outcomes and xenograft function, we generated transcriptomic, lipidomic, proteomic and metabolomics datasets, across blood and tissue samples collected every 6 hours over the 3-day procedures. Results Single-cell datasets in the 3-day pig xenograft-decedent models show dynamic immune activation processes. We observe specific scRNA-seq, snRNA-seq and geospatial transcriptomic changes of early immune-activation leading to pronounced downstream T-cell activity and hallmarks of early antibody mediated rejection (AbMR) and/or ischemia reperfusion injury (IRI) in the first xenograft recipient. Using longitudinal multiomic integrative analyses from blood in addition to antigen presentation pathway enrichment, we also observe in the first xeno-heart recipient significant cellular metabolism and liver damage pathway changes that correlate with profound physiological dysfunction whereas, these signals are not present in the other xenograft recipient. Conclusions Single-cell and multiomics approaches reveal fundamental insights into early molecular immune responses indicative of IRI and/or early AbMR in the first human decedent, which was not evident in the conventional histological evaluations.
BibTeX
@misc{schmauch2023integrative,
  author = {Eloi Schmauch and Brian Piening and Bo Xia and Chen Ouyang and Jeffrey Stern and Weimin Zhang and Alexa K. Dowdell and Bao‐Li Loza and Maedeh Mohebnasab and Loren Gragert and Karen Khalil and Brendan Camellato and Michelli F. Oliveira and Darragh P. O’Brien and Elaina Weldon and Xiangping Lin and Hui Gao and Larisa Kagermazova and Jacqueline Kim and Alexandre Loupy and Adriana Heguy and Sarah E. Taylor and Florrie Zhu and Sarah Gao and Divya Gandla and K Srinavas Reddy and Andrew C. Chang and Basil Michael and Lihua Jiang and Ruiqi Jian and Navneet Narula and Suvi Linna-Kuosmanen and Minna U. Kaikkonen and Marc I. Lorber and Manolis Kellis and Vasishta Tatapudi and David Ayares and Adam Griesemer and Massimo Mangiola and Harvey I. Pass and M Snyder and Robert A. Montgomery and Jef D. Boeke and Brendan J. Keating},
  title = {{Integrative Multi-omic Profiling of Two Human Decedents Receiving Pig Heart Xenografts Reveals Strong Perturbations in Early Immune-Cell and Cellular Metabolism Responses}},
  year = {2023},
  doi = {10.1101/2023.06.05.543406},
  howpublished = {bioRxiv},
}
Figure